Suppr超能文献

外用1%特比萘芬乳膏联合二氧化碳点阵激光与口服伊曲康唑治疗甲真菌病的随机对照试验

Fractional CO2 laser with topical 1% terbinafine cream versus oral itraconazole in the management of onychomycosis: A randomized controlled trial.

作者信息

Ranjan Eeshaan, Arora Sandeep, Sharma Neha

机构信息

Department of Dermatology, Military Hospital, Jammu, Jammu and Kashmir, India.

Department of Dermatology, Base Hospital, New Delhi, Delhi, India.

出版信息

Indian J Dermatol Venereol Leprol. 2023 Jan-Frebuary;89(1):47-53. doi: 10.25259/IJDVL_98_2021.

Abstract

Background Onychomycosis accounts for 20-40% of all nail disorders. It is difficult to cure with resistance to anti-fungal drugs, their side effects and drug interactions limiting treatment options. Itraconazole is a widely accepted oral medication used for onychomycosis while fractional CO2 laser along with a topical anti-fungal has shown promising results for nail plate clearance in onychomycosis. Aim To compare the efficacy of fractional CO2 laser with 1% terbinafine cream versus itraconazole in the management of onychomycosis. Methods A prospective, randomised, single-centre, two-arm, parallel-group interventional study was conducted at Command Hospital Air Force, Bangalore. Onychomycosis cases confirmed by KOH mount/culture-positive were included. Patients were randomly divided into two groups. Group A received 4 sessions of fractional CO2 laser every fourth week with twice-daily application of 1% terbinafine cream; Group B received one-week pulse therapy with capsule itraconazole once every four-week for three pulses. The response was assessed by Onychomycosis Severity Index, a validated onychomycosis assessment scale, at baseline and at six months. Results Group A had 50 patients with a total of 98 nails. Clinical improvement was seen in 83/98 (84.7%) nails. The average reduction in Onychomycosis Severity Index was 8.65 (P < 0.05). Group B had 50 patients with a total of 136 nails. Clinical improvement was seen in 104/136 (76.5%) nails. The average reduction in Onychomycosis Severity Index was 7.37 (P < 0.05). Both groups showed statistically significant improvement measured by 'Reduction in Onychomycosis Severity Index' at six months; however, there was no significant difference between the two arms. Limitations The main limitations of the study are the small sample size and lack of long-term follow-up to assess recurrence of infection. Conclusion Fractional CO2 laser with 1% terbinafine cream is an effective and safe method for inducing nail clearance in onychomycosis and has efficacy similar to itraconazole pulse therapy.

摘要

背景

甲癣占所有指甲疾病的20%-40%。由于对抗真菌药物产生耐药性、药物副作用以及药物相互作用限制了治疗选择,甲癣难以治愈。伊曲康唑是一种广泛用于治疗甲癣的口服药物,而分次二氧化碳激光联合外用抗真菌药物在清除甲癣甲板方面已显示出有前景的结果。目的:比较分次二氧化碳激光联合1%特比萘芬乳膏与伊曲康唑治疗甲癣的疗效。方法:在班加罗尔空军司令部医院进行了一项前瞻性、随机、单中心、双臂、平行组干预性研究。纳入经氢氧化钾涂片/培养确诊为阳性的甲癣病例。患者被随机分为两组。A组每四周接受4次分次二氧化碳激光治疗,同时每天两次外用1%特比萘芬乳膏;B组每四周接受一次为期一周的伊曲康唑胶囊冲击疗法,共进行三个疗程。在基线和六个月时通过甲癣严重程度指数(一种经过验证的甲癣评估量表)评估反应。结果:A组有50例患者,共98个指甲。98个指甲中的83个(84.7%)出现临床改善。甲癣严重程度指数的平均降低值为8.65(P<0.05)。B组有50例患者,共136个指甲。136个指甲中的104个(76.5%)出现临床改善。甲癣严重程度指数的平均降低值为7.37(P<0.05)。两组在六个月时通过“甲癣严重程度指数降低值”衡量均显示出统计学上的显著改善;然而,两组之间没有显著差异。局限性:该研究的主要局限性是样本量小且缺乏长期随访以评估感染复发情况。结论:分次二氧化碳激光联合1%特比萘芬乳膏是一种有效且安全的诱导甲癣指甲清除的方法,其疗效与伊曲康唑冲击疗法相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验